Gender‐affirming hysterectomy in the United States: A comparative outcomes analysis and potential implications for uterine transplantation
Perspectives on Sexual and Reproductive Health · 2023
DOI: 10.1363/psrh.12246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perspectives on Sexual and Reproductive Health, 2023. Verfasst von Nicolette V Siringo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hansjörg Wyss Department of Plastic Surgery, New York University Langone Health, New York, New York, USA. Hauptthemen laut MEDLINE: Hysterectomy, Transgender Persons. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Purpose
Hysterectomy is a gynecological procedure sometimes performed as part of the gender‐affirming process for transgender and gender‐expansive patients assigned female at birth. Our goal was to compare surgical outcomes between patients undergoing gender‐affirming hysterectomy and patients undergoing hysterectomy for benign menstrual disorders. We then explored the implications of gender‐affirming hysterectomy for uterine transplantation.
Methods
We performed a retrospective cohort study using data from the American College of Surgeons National Surgical Quality Improvement Program database from 2009 through 2018. We identified patients undergoing hysterectomy in the United States based on Current Procedural Terminology code. We used the International Classification of Diseases 9 or 10 codes to identify patients with benign menstrual disorders (non‐gender‐affirming group) and gender dysphoria (gender‐affirming group). We compared patient characteristics and surgical complications.
Results
Of the 40,742 patients that met inclusion criteria, 526 (1.3%) patients were individuals with gender dysphoria. Compared to patients who underwent hysterectomy for benign menstrual disorders, gender‐affirming patients were younger, were healthier, had a lower prevalence of diabetes, and were more likely to undergo surgery in the outpatient setting, with shorter time to discharge. Complication rates were similar between groups. Logistic regression controlling for the American Society of Anesthesiology classification determined the difference of return to the operating room was not statistically significant (OR 1.082; 95% CI, 0.56–2.10; p = 0.816).
Conclusion
Gender‐affirming hysterectomy has a safety profile similar to hysterectomy performed for benign menstrual disorders. Researchers should further explore the possibility of uterus donation among these patients as they may be suitable candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hansjörg Wyss Department of Plastic Surgery, New York University Langone Health, New York, New York, USA.
- Division of Medical Ethics, Department of Population Health, New York University Langone Health, New York, New York, USA.
Zitieren
APA
Siringo, N. V., Boczar, D., Berman, Z. P., Chaya, B. F., Kimberly, L., Rodriguez Colon, R., Trilles, J., Brydges, H., & Rodriguez, E. D. (2023). Gender‐affirming hysterectomy in the United States: A comparative outcomes analysis and potential implications for uterine transplantation. Perspectives on Sexual and Reproductive Health. https://doi.org/10.1363/psrh.12246
Vancouver
Siringo NV, Boczar D, Berman ZP, Chaya BF, Kimberly L, Rodriguez Colon R, et al. Gender‐affirming hysterectomy in the United States: A comparative outcomes analysis and potential implications for uterine transplantation. Perspectives on Sexual and Reproductive Health. 2023. doi:10.1363/psrh.12246
BibTeX
@article{Siringo2023,
author = {Siringo, Nicolette V and Boczar, Daniel and Berman, Zoe P and Chaya, Bachar F and Kimberly, Laura and Rodriguez Colon, Ricardo and Trilles, Jorge and Brydges, Hilliard and Rodriguez, Eduardo D},
title = {Gender‐affirming hysterectomy in the United States: A comparative outcomes analysis and potential implications for uterine transplantation},
journal = {Perspectives on Sexual and Reproductive Health},
year = {2023},
doi = {10.1363/psrh.12246}
}
EUVIMED